WHITE PAPER
Time to Discover the Power of Data for Improving Access and Care
2021 - Oncology data landscape in Middle East region
Aug 17, 2021
Download
Over the past decade, oncology has seen unprecedented innovation: treatment paradigms are shifting from tumour- to mutation- and biomarker-based paradigms, and gene editing is now within the realm of the possible. Today, healthcare stakeholders have already started recognising the transformation of single biomarker testing to next-generation sequencing (NGS) testing, to simplify the personalised treatment plan at beginning of diagnosis.
Contact Us